# Association between genomic features and toxic metal(loid) accumulation in left-sided and right-sided colorectal cancer

**Authors:** Shoujiang Yu, Min Fu, Yurong Wang, Ling Lin, Shushen Ji, Feng Du, Li Song, Mengzhu Wang, Yufeng Zhai, Jiangman Zhao, Min Huang

PMC · DOI: 10.3389/fonc.2025.1584424 · Frontiers in Oncology · 2025-07-04

## TL;DR

This study explores how toxic metal levels in the blood relate to genetic differences in left- and right-sided colorectal cancer tumors.

## Contribution

The study identifies associations between blood toxic metal(loid) levels and genomic mutation patterns in left- and right-sided colorectal cancer.

## Key findings

- Left-sided tumors showed higher mutation rates in TP53 and APC genes compared to right-sided tumors.
- Blood mercury levels correlated positively with the number of somatic variations in tumors.
- Blood arsenic, strontium, and barium levels were higher in patients with MSS tumors compared to those with MSI tumors.

## Abstract

Colorectal cancer (CRC) is a high heterogenous disease of genetic variations, which was influenced by tumor anatomic location and toxic metal(loid) accumulation. Current study aims to investigate genomic heterogeneity of CRC influenced by toxic metal(loid) accumulation based on tumor anatomic location.

In this study, a total of 94 patients with CRC were recruited including 69 left-sided tumors and 35-right sided tumors. The genomic mutation landscape and microsatellite instability (MSI) of tumors were analyzed. The blood metal(loid) element levels were tested by inductively coupled plasma emission spectrometry (ICP-MS).

A total of 642 somatic variations across 24 genes were identified in 94 CRC patients. The most frequently mutated genes were TP53 (n=83%), followed by APC (n=67%), KRAS (52%), EGFR (41%) and PIK3CA (33%). The mutated frequency of TP53 (88.4% vs 68.0%, P=0.02) and APC (75.4% vs 44.0%, P=0.004) in left-sided tumors were significantly higher than that of right-sided tumors. Blood Hg concentration was significantly and positively correlated with numbers of variations per tumor sample (r=0.237, P=0.021). Blood As (r= -0.207, P=0.046), Sr (r= -0.256, P=0.013) and Ba (r= -0.274, P=0.08) level of patients with MSS tumor was significantly higher than that of patients with MSI tumor. Cd level of patients with tumor in left side was significantly lower than that in right side (P=0.028).

This study presented the comprehensive genomic landscape of 94 CRC patients according to tumor anatomic location. The blood toxic metal(loid) accumulation may have potential influence on genomic features.

## Linked entities

- **Genes:** TP53 (tumor protein p53) [NCBI Gene 7157], APC (APC regulator of Wnt signaling pathway) [NCBI Gene 324], KRAS (KRAS proto-oncogene, GTPase) [NCBI Gene 3845], EGFR (epidermal growth factor receptor) [NCBI Gene 1956], PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha) [NCBI Gene 5290]
- **Chemicals:** Hg (PubChem CID 23931), As (PubChem CID 1549433), Sr (PubChem CID 104798), Ba (PubChem CID 243), Cd (PubChem CID 23973)
- **Diseases:** colorectal cancer (MONDO:0005575), CRC (MONDO:0005575)

## Full-text entities

- **Genes:** APC (APC regulator of Wnt signaling pathway) [NCBI Gene 324] {aka BTPS2, DESMD, DP2, DP2.5, DP3, GS}, TP53 (tumor protein p53) [NCBI Gene 7157] {aka BCC7, BMFS5, LFS1, P53, TRP53}, KRAS (KRAS proto-oncogene, GTPase) [NCBI Gene 3845] {aka 'C-K-RAS, C-K-RAS, CFC2, K-RAS2A, K-RAS2B, K-RAS4A}, EGFR (epidermal growth factor receptor) [NCBI Gene 1956] {aka ERBB, ERBB1, ERRP, HER1, NISBD2, NNCIS}, PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha) [NCBI Gene 5290] {aka CCM4, CLAPO, CLOVE, CWS5, HMH, MCAP}
- **Diseases:** MSI tumor (MESH:D053842), MSS (MESH:D013132), tumor (MESH:D009369), CRC (MESH:D015179)
- **Chemicals:** metal (MESH:D008670), Cd (MESH:D002104), Blood Hg (-), Sr (MESH:D013324)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12270859/full.md

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12270859/full.md

## References

36 references — full list in the complete paper: https://tomesphere.com/paper/PMC12270859/full.md

---
Source: https://tomesphere.com/paper/PMC12270859